Liuting Zeng
Overview
Explore the profile of Liuting Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng L, Xiang W, Xiao W, Wu Y, Sun L
MedComm (2020)
. 2025 Mar;
6(3):e70101.
PMID: 40060194
Neutrophil extracellular traps (NETs) are unique fibrous structures released by neutrophils in response to various pathogens, exhibiting both anti-inflammatory and proinflammatory effects. In autoimmune conditions, NETs serve as crucial self-antigens...
2.
Zeng L, Liu C, Wu Y, Liu S, Zheng Y, Hao W, et al.
Stem Cell Res Ther
. 2025 Feb;
16(1):65.
PMID: 39934871
Objective: This study aims to assess the effectiveness and safety of mesenchymal stem cell (MSC) transplantation in the treatment of autoimmune and rheumatic immune diseases through randomized controlled trials (RCTs)....
3.
Zeng L, Li Y, Xiang W, Xiao W, Long Z, Sun L
J Autoimmun
. 2024 Dec;
150():103350.
PMID: 39700677
Chimeric antigen receptor T (CAR-T) cells are genetically engineered T cells expressing transmembrane chimeric antigen receptors with specific targeting abilities. As an emerging immunotherapy, the use of CAR-T cells has...
4.
Ge L, Zhang T, Yu J, Lu X, Xiao S, Zhang T, et al.
Biomed Pharmacother
. 2024 Dec;
181:117741.
PMID: 39648112
No abstract available.
5.
Ge Q, Zhang T, Yu J, Lu X, Xiao S, Zhang T, et al.
Biomed Pharmacother
. 2024 Nov;
181:117706.
PMID: 39581144
Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by elevated pulmonary vascular resistance, progressive increases in pulmonary artery pressures, ultimately leading to right-sided heart failure, and potentially mortality....
6.
Long Z, Xiang W, Xiao W, Min Y, Qu F, Zhang B, et al.
Front Immunol
. 2024 Nov;
15:1432625.
PMID: 39524446
Artemisinin and its derivatives are widely recognized as first-line treatments for malaria worldwide. Recent studies have demonstrated that artemisinin-based antimalarial drugs, such as artesunate, dihydroartemisinin, and artemether, not only possess...
7.
Zhao Q, Mo Z, Zeng L, Yuan Y, Wang Y, Wang Y
Molecules
. 2024 Nov;
29(21).
PMID: 39519815
Hydroxycamptothecin (HCPT) is commonly used in the treatment of liver cancer; however, its low water solubility and poor stability significantly limit its clinical application. In recent years, research on exosomes...
8.
Long Z, Zeng L, Yang K, Chen J, Luo Y, Dai C, et al.
Front Pharmacol
. 2024 Oct;
15:1440584.
PMID: 39449973
Objective: To assess the efficacy and safety of iguratimod (IGU) in the treatment of inflammatory arthritis and degenerative arthritis. Methods: Initially, randomized controlled trials (RCTs) on using IGU in treating...
9.
Zeng L, Yang K, Yu G, Hao W, Zhu X, Ge A, et al.
Cell Death Dis
. 2024 Oct;
15(10):765.
PMID: 39433577
No abstract available.
10.
Zeng L, Yang K, Wu Y, Yu G, Yan Y, Hao M, et al.
J Autoimmun
. 2024 Aug;
148:103291.
PMID: 39146891
BLyS and APRIL have the capability to bind to B cells within the body, allowing these cells to evade elimination when they should naturally be removed. While BLyS primarily plays...